ArisGlobal Launches XDI NavaX Data Intelligence and AI Agents
ArisGlobal, an AI-first technology company and creator of LifeSphere®, has introduced ArisGlobal XDI NavaX, a suite of new AI-powered solutions designed to accelerate AI operationalization across life sciences organizations.
The announcement came during Breakthrough 2026, the company’s annual industry event held in Madrid, Spain. Notably, the launch includes the next-generation XDI data intelligence cortex, three advanced AI agents, and NavaX Translation for pharmacovigilance (PV) case data workflows.
Together, these innovations aim to help organizations move from AI experimentation to enterprise-wide deployment.
ArisGlobal XDI NavaX Strengthens Data Intelligence Across Pharma
The ArisGlobal XDI NavaX platform acts as a next-generation data intelligence cortex capable of accessing information from multiple systems and functions. As a result, teams can make consistent and explainable decisions across the pharma R&D ecosystem.
Unlike workflow-specific tools, XDI creates a system-agnostic foundation that unifies meaning, context, and intent. Consequently, decisions across Safety, Regulatory, Clinical, Quality, and Manufacturing remain aligned with shared evidence and governance.
This approach promotes confident AI adoption while reducing operational risk and interpretive gaps between teams.
“The challenge for life sciences isn’t just adopting AI — it’s operationalizing it at scale,” said Aman Wasan, CEO of ArisGlobal. Therefore, the latest product enhancements aim to turn AI into a reliable foundation for enterprise decision-making.
New ArisGlobal XDI NavaX AI Agents Enhance Compliance and Insights
ArisGlobal has expanded its NavaX Agents Suite with three intelligent agents that automate complex regulatory and analytical processes.
-
Intelligence Agents: Automatically interpret regulatory guidelines, convert them into rule checklists, and evaluate submission dossiers with compliance scores and justifications.
-
Distribution Agents: Continuously validate compliance by analyzing evolving regulations and triggering governed change workflows when discrepancies appear.
-
Signals Agents: Act as intelligent assistants that interpret user intent, select analytical methods, and execute workflows using a reasoning-based orchestration layer.
Collectively, these agents help organizations improve submission quality, maintain compliance, and generate faster insights.
NavaX Translation Accelerates Global Case Data Intake
ArisGlobal XDI NavaX now includes certified translation capabilities through a strategic partnership with TransPerfect Life Sciences.
Intelligent language detection instantly routes non-English safety forms for translation using pharma-specific language models and expert linguists. Meanwhile, seamless API integration returns translated content directly into LifeSphere.
As a result, translation management time drops from roughly five hours per case to under one minute.
This automation significantly reduces manual effort while improving speed and accuracy in global pharmacovigilance workflows.
Industry Shift Toward Scalable AI in Life Sciences
“We’re witnessing a fundamental shift in how technology empowers life sciences teams,” said Ann-Marie Orange, CIO and Global Head of R&D at ArisGlobal.
Indeed, the industry is evolving from automating individual tasks to orchestrating intelligence across entire operational ecosystems. Ultimately, this shift enables smarter decisions, faster insights, and scalable AI adoption.
Breakthrough 2026 gathered executives, industry leaders, and experts to explore the theme of “Operationalizing AI.” The event highlighted how proven AI use cases are rapidly becoming everyday practice across life sciences.
What ArisGlobal XDI NavaX Means for the Future of AI
The launch of ArisGlobal XDI NavaX reflects growing demand for trusted, governed AI platforms in highly regulated industries.
Moving forward, organizations that successfully operationalize AI will likely gain a competitive advantage through improved efficiency, stronger compliance, and better data-driven decisions.
Ultimately, ArisGlobal positions itself at the forefront of enterprise AI transformation in life sciences.
Read Also: Elisa Beth Haransky-Beck, OD releases ‘Enlivening Consciousness’
